Daniel E Greenleaf's Net Worth

$14.2 Million

Estimate Recalculated May 10, 2024 03:35PM EST

Who is Daniel E Greenleaf?

Daniel E Greenleaf has an estimated net worth of $14.2 Million. This is based on reported shares across multiple companies, which include ModivCare Inc, BioScrip, Inc., APRIA HEALTHCARE GROUP INC, and VioQuest Pharmaceuticals, Inc..

SEC CIK

Daniel E Greenleaf's CIK is 0001208492

Past Insider Trading and Trends

2005 was Daniel E Greenleaf's most active year for acquiring shares with 9 total transactions. Daniel E Greenleaf's most active month to acquire stocks was the month of January. 2019 was Daniel E Greenleaf's most active year for disposing of shares, totalling 7 transactions. Daniel E Greenleaf's most active month to dispose stocks was the month of January. 2021 saw Daniel E Greenleaf paying a total of $100,425.85 for 37,409 shares, this is the most they've acquired in one year. In 2021 Daniel E Greenleaf cashed out on 1,179 shares for a total of $210,486.87, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ModivCare Inc (MODV) Snapshot price: $40.73

CEO and President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+26.14%
9.17K
—
—
44.25K
Feb 8
Form 4
+1.68%
581
$172.85
$100,425.85
35.08K
Sep 15
Form 4/A
—
0
—
—
0
Feb 10
Form 4
-3.30%
-1.18K
$178.53
-$210,486.87
34.5K
Feb 13
Form 4
+15.60%
4.74K
—
—
35.14K
Feb 10
Form 4
-4.50%
-1.46K
$142.97
-$208,307.29
30.93K
Dec 11
Form 4
+61.12%
12.29K
—
—
32.39K
Feb 13
Form 4
∞
20.1K
—
—
20.1K
Dec 11
Form 3
—
0
—
—
0
No matching records found

BioScrip, Inc. (OPCH) Snapshot price: $31.565

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+56.17%
134.99K
$2.00
-$125,468.00
375.31K
May 16
Form 4
+226.09%
166.62K
$1.82
-$123,749.08
240.31K
Apr 18
Form 4
+137.73%
42.7K
$3.59
-$77,737.86
73.7K
Feb 8
Form 4
—
0
—
—
0
May 3
Form 4
—
0
—
—
0
Apr 11
Form 4
—
0
—
—
0
Nov 28
Form 4
+93.75%
15K
$2.03
$30,495.00
31K
Nov 9
Form 4
—
0
—
—
0
Feb 8
Form 4
—
0
—
—
0
Dec 1
Form 4
∞
16K
$1.30
$20,784.00
16K
Nov 10
Form 3
—
0
—
—
0
No matching records found

APRIA HEALTHCARE GROUP INC No price found

President, Coram Infusion Div.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 28
Form 4
—
0
—
—
0
Apr 7
Form 3
—
0
—
—
0
No matching records found

VioQuest Pharmaceuticals, Inc. No price found

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 29
Form 4
+28.00%
17.5K
$0.57
$9,950.00
80K
Feb 16
Form 4
+4.17%
2.5K
$0.58
$1,450.00
62.5K
Feb 14
Form 4
—
0
—
—
0
Oct 18
Form 4
+20.00%
10K
$0.94
$9,350.00
60K
Apr 4
Form 4
+25.00%
10K
$0.85
$8,500.00
50K
Mar 31
Form 4
+33.33%
10K
$0.80
$8,000.00
40K
Dec 14
Form 4
+50.00%
10K
$0.80
$8,000.00
30K
Dec 9
Form 4
—
0
—
—
0
Oct 19
Form 4
+33.33%
5K
$0.95
$4,750.00
20K
Feb 23
Form 4
+50.00%
5K
$0.83
$4,150.00
15K
Feb 17
Form 4
∞
10K
$0.89
$8,850.00
10K
Feb 1 - Feb 11
Form 3
—
0
—
—
0
No matching records found